ENVB · Enveric Biosciences, Inc. · Exempt Offerings
$1.52
+0.03 (+2.01%)
At close · Nov 12
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern for a period of one year from the issuance of these unaudited condensed consolidated financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$6.80M
Shares
4.48M
Volume · Nov 12
32.25K
Avg daily vol (3M)
71.41K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-05-04 | New | Biotechnology | $5,000,002 | $5,000,002 | 06b |
| 2026-02-11 | New | Biotechnology | $1,450,017 | $1,450,017 | 06b |
| 2025-12-23 | New | Biotechnology | $106,598 | $106,598 | 06b |
| 2025-10-03 | New | Pharmaceuticals | Indefinite | $0 | 06b |
| 2023-04-19 | Amendment | Pharmaceuticals | $12,780,000 | $12,780,000 | 06b |
| 2022-08-05 | New | Pharmaceuticals | $8,617,500 | $8,617,500 | 06b |
| 2021-02-24 | New | Pharmaceuticals | $8,398,625 | $0 | 06b |
| 2021-01-20 | New | Pharmaceuticals | $8,249,959 | $0 | 06b |
Showing 1–8 of 8 filings
Key facts
CIK
890821
CUSIP
29405E505
13F (30d)
16 filings
12 filers
Visit website
Investor relations